intoDNA

🚀 We’re gearing up for an action-packed month! 🚀 intoDNA is excited to be attending two major conferences in October, and we can't wait to connect with industry leaders and innovators. 🎉 As a teaser, we invite you to explore STRIDE™ – the groundbreaking technology that has revolutionized DNA damage detection. From research to practical applications in various fields, STRIDE™ is setting new standards in precision and sensitivity. Our experts will be on-site, ready to discuss how STRIDE™ can transform your work. Stay tuned for more details, and we hope to see you there! 👋 #STRIDE #DNADamageDetection #Innovation #intoDNA #TechInnovation #Conferences #DDR

Exciting news! 🎉 Magda Kordon and Zsombor Prucsi will be attending the American Association for Cancer Research (AACR) Annual Meeting 2025 from April 25–30! If you’re planning to be there too, don’t miss the chance to connect with our team — we’d love to meet you!

Sukces Pisany Szminką x We Did It In Poland - thank you for inviting us to be one of the 40 Polish Innovations! 💡 We are excited to be among such inspiring company! #wediditinpoland #innovations #stride

Sukces Pisany Szminką x We Did It In Poland - thank you for inviting us to be one of the 40 Polish Innovations! 💡 We are excited to be among such inspiring company! #wediditinpoland #innovations #stride

🚀 Following up on our previous post, our CTO, Kamil Solarczyk, is back to give you an in-depth look at our functional assays. In this video, we’re diving deeper into how our technology can give you insights into how to measure the activition and efficiency of DNA repair pathways. As we continue to innovate, we’re more excited than ever about the future, and there’s much more to come! Stay tuned #intoDNA #DDR #DNARepair #innovation https://lnkd.in/dzPgqr7q

🚀 Exciting Updates Ahead! 🚀 We have some great news coming your way soon!  But before we dive into what’s next, let’s take a step back and revisit the foundation of our technology. In this video, our CEO, Magda Kordon, provides a great introduction to our work—an essential starting point for the exciting developments we’ll be sharing soon. Stay tuned! 🔬✨ #intoDNA #DDR #DNADamage https://lnkd.in/d-6dS9S4

🚨 New Poster Alert! 🚨 We’re excited to share our latest poster, showcased at the DDR Inhibitors Summit: "STRIDE™: A Platform for Quantitative DNA Damage Response Dissection" STRIDE™ directly labels DNA break sites, making it the most proximal marker of DNA damage available today. Not only does it quantify the number of DNA breaks with precision, but it also enables real functional readouts of DNA repair activity. We’d love to hear your thoughts—drop us a comment! 👇 #intoNDA #DDR #DNADamage #STRIDE #DNARepair https://lnkd.in/dtr6TTpZ

A huge thank you to our ✨ Gold and Bronze sponsors ✨ AstraZeneca, intoDNA & LUMICKS for their incredible support of the #DDRCT conference! 🙏 Your contributions have helped us bring together an outstanding lineup of speakers. Don’t forget to register and submit your abstract for a chance to present before tomorrow’s deadline! ➡️ https://lnkd.in/exgWZba2

🌍 World Cancer Day – A Day of Reflection, Hope, and Action Today, on #WorldCancerDay, our thoughts are with those affected by cancer—the patients, their loved ones, and the countless scientists and healthcare professionals dedicating their lives to finding better treatments. At intoDNA, we stand with this global community. By providing our cutting-edge technology, we contribute to the development of more effective and personalized therapies—because every patient deserves the best possible care. Progress in cancer treatment is only possible through innovation, collaboration, and unwavering dedication. To all the researchers, clinicians, and organizations working tirelessly to push the boundaries of science: we see you, we appreciate you, and we are proud to support your mission. Together, we can make a difference.  #WorldCancerDay #CancerResearch #intoDNA

From Boston to Hawaii! 🌎✈️ After an inspiring few days at the DDR Inhibitors Summit, the intoDNA team is heading to Hawaii for the 13th AACR-JCA Joint Conference! Our colleagues Maja Bialecka, PhD and Robert Wójcicki, VMD aren’t coming empty-handed—we're excited to present a poster (#B45) on a topic that couldn't be more timely. We are in an era where quantitative, sensitive, and highly selective biomarkers are not just shaping research but defining the success of therapies and the well-being of patients. Don’t miss the chance to connect with us at Poster Session B! 🧬 Title: Direct DNA damage detection with STRIDE™: a quantitative step beyond γH2AX 📅 Date: February 3 📍 Location: Mondarchy 5-7 ⏰ Time: 5:30–7:30 p.m. Looking forward to insightful discussions—see you there! 👋 #AACR #JCA #DNADamage #intoDNA